Facebook From Breakthrough to Standard of Care: How NK1 Receptor Antagonists Are Transforming CINV Prevention and Enhancing Cancer Treatment Outcomes
Logo

From Breakthrough to Standard of Care: How NK1 Receptor Antagonists Are Transforming CINV Prevention and Enhancing Cancer Treatment Outcomes

クレジット
Avatar
インタビューワー
From Breakthrough to Standard of Care: How NK1 Receptor Antagonists Are Transforming CINV Prevention and Enhancing Cancer Treatment Outcomes-1
シェア
金金の他の作品